Culver City, CA, Feb. 22, 2018 -- eWellness Healthcare Corporation – (OTCQB: EWLL) – a provider of the state of the art PHZIO platform for the physical therapy and telehealth markets, announced today that has signed an Partnership Agreement to co-market the Company’s PHZIO platform with LifeWallet https://www.lifewallet.com which provides employers, communities and healthcare professionals with a simple, consumer centric, integrated platform to assess the health of their population and monitor their progress towards better health.
About eWellness
eWellness Healthcare Corporation (OTCQB: EWLL) is the first physical therapy telehealth company to offer insurance reimbursable real-time distance monitored treatments. Our business model is to license our PHZIO (“PHZIO”) platform to any physical therapy (“PT”) clinic in the U.S. and or have large-scale employers use our PHZIO platform as a fully PT monitored corporate wellness program. The Company’s PHZIO home physical therapy exercise platform has been designed to disrupt the $30 billion physical therapy and the $8 billion corporate wellness industries. PHZIO re-defines the way physical therapy can be delivered. PHZIO is the first real-time remote monitored 1-to-many physical therapy platform for home use. Due to the real-time patient monitoring feature, the PHZIO platform is insurance reimbursable.
For more information on eWellness go to:
http://www.ewellnesshealth.com/
http://phzio.com/
About LifeWallet:
LifeWallet™ is transforming the delivery of care and revolutionizing the health care to wellness process with a consumer centric health platform and modern digital assistants that promote better outcomes. LifeWallet’s employees are dedicated to making the best products on earth. LifeWallet™ is creating a one of a kind technology region in South and has brought in developers from leading technology companies including Apple.
For more information, visit www.lifewallet.com.
Safe Harbor Statement
This news release includes certain information that may constitute forward-looking statements. Forward-looking statements are typically identified by terminology such as “could,” “may,” “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “proposed,” “planned,” “potential” and similar expressions, or are those, which, by their nature, refer to future events. All statements, other than statements of historical fact, included herein, including statements about eWellness’ beliefs and expectations, are forward-looking statements. Forward-looking information is necessarily based upon a number of assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking information. Although eWellness believes that such statements are reasonable, it can give no assurance that such forward-looking information will prove to be accurate. eWellness cautions investors that any forward-looking statements by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward-looking statements as a result of various factors. Accordingly, due to the risks, uncertainties and assumptions inherent in forward-looking information, readers and prospective investors in the Company’s securities should not place undue reliance on forward-looking information. All forward-looking information contained in this press release is given as of the date hereof, and is based upon the opinions and estimates of management and information available to management as at the date hereof and is subject to change. The Company assumes no obligation to revise or update forward-looking information to reflect new circumstances, whether as a result of new information, future events or otherwise, except as required by law.
Press Contacts: Lewis Matusow [email protected] (305) 775-6575 For additional information on eWellness Healthcare Corporation and its PHZIO telemedicine products please contact Mr. Darwin Fogt, CEO: 1-855-470-1700


DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Anta Sports Expands Global Footprint With Strategic Puma Stake
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss 



